Ignite Creation Date:
2025-12-26 @ 10:16 PM
Ignite Modification Date:
2026-03-09 @ 5:50 AM
Study NCT ID:
NCT01663012
Status:
COMPLETED
Last Update Posted:
2016-02-24
First Post:
2012-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
Sponsor:
Lawrence Recht
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB-24833
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |